{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:10:12Z","timestamp":1783105812308,"version":"3.54.6"},"reference-count":19,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2023.14185","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T12:13:02Z","timestamp":1702383182000},"source":"Crossref","is-referenced-by-count":5,"title":["Successful liver transplantation with ctDNA clearance after PD\u20111 inhibitor plus FOLFOX\u2011HAIC treatment in HCC: A case report"],"prefix":"10.3892","volume":"27","author":[{"given":"Yuanyuan","family":"Zhao","sequence":"first","affiliation":[{"name":"Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[{"name":"Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobin","family":"Huang","sequence":"additional","affiliation":[{"name":"Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[{"name":"Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhishui","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"key":"key20240125114948_b1-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrgastro.2016.193","article-title":"Liver transplantation for hepatocellular carcinoma: Outcomes and novel surgical approaches","volume":"14","author":"Sapisochin","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20240125114948_b2-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/lt.24169","article-title":"Downstaging hepatocellular carcinoma: A systematic review and pooled analysis","volume":"21","author":"Parikh","year":"2015","journal-title":"Liver Transpl"},{"key":"key20240125114948_b3-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/S1470-2045(11)70175-9","article-title":"Recommendations for liver transplantation for hepatocellular carcinoma: An international consensus conference report","volume":"13","author":"Clavien","year":"2012","journal-title":"Lancet Oncol"},{"key":"key20240125114948_b4-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.cgh.2022.02.018","article-title":"UNOS down-staging criteria for liver transplantation of hepatocellular carcinoma: Systematic review and meta-analysis of 25 studies","volume":"21","author":"Tan","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20240125114948_b5-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J Clin Oncol"},{"key":"key20240125114948_b6-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3350\/kjhep.2010.16.4.355","article-title":"A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma","volume":"16","author":"Kim","year":"2010","journal-title":"Korean J Hepatol"},{"key":"key20240125114948_b7-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"17588359211002720","DOI":"10.1177\/17588359211002720","article-title":"Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy versus lenvatinib alone for advanced hepatocellular carcinoma","volume":"13","author":"He","year":"2021","journal-title":"Ther Adv Med Oncol"},{"key":"key20240125114948_b8-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.hbpd.2020.06.008","article-title":"Role of selected criteria and preventive chemotherapy in tumor recurrence after liver transplantation","volume":"19","author":"Wang","year":"2020","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"key20240125114948_b9-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"key20240125114948_b10-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1016\/j.transproceed.2015.10.029","article-title":"Chinese pediatric organ donation with scheduled cardiac arrest after brain death: A novel China classification beyond maastricht","volume":"47","author":"Wu","year":"2015","journal-title":"Transplant Proc"},{"key":"key20240125114948_b11-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"810251","DOI":"10.3389\/fmolb.2021.810251","article-title":"Case report: One-year delay in the effect of conversion surgery therapy for advanced hepatocellular carcinoma after systemic therapy","volume":"8","author":"Xie","year":"2021","journal-title":"Front Mol Biosci"},{"key":"key20240125114948_b12-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5582\/bst.2021.01091","article-title":"Conversion therapy and maintenance therapy for primary hepatocellular carcinoma","volume":"15","author":"Zhou","year":"2021","journal-title":"Biosci Trends"},{"key":"key20240125114948_b13-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1200\/JCO.21.00608","article-title":"Hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin versus transarterial chemoembolization for large hepatocellular carcinoma: A randomized phase III trial","volume":"40","author":"Li","year":"2022","journal-title":"J Clin Oncol"},{"key":"key20240125114948_b14-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/ajt.15617","article-title":"Fatal hepatic necrosis after nivolumab as a bridge to liver transplant for HCC: Are checkpoint inhibitors safe for the pretransplant patient","volume":"20","author":"Nordness","year":"2020","journal-title":"Am J Transplant"},{"key":"key20240125114948_b15-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.3390\/cancers14092056","article-title":"Immune checkpoint inhibitors as therapy to down-stage hepatocellular carcinoma prior to liver transplantation","volume":"14","author":"Katariya","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20240125114948_b16-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40425-019-0585-1","article-title":"Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: An institutional experience and a systematic review of the literature","volume":"7","author":"Abdel-Wahab","year":"2019","journal-title":"J Immunother Cancer"},{"key":"key20240125114948_b17-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1111\/ajt.16448","article-title":"PD-1 inhibitor as bridge therapy to liver transplantation","volume":"21","author":"Tabrizian","year":"2021","journal-title":"Am J Transplant"},{"key":"key20240125114948_b18-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1158\/2159-8290.CD-17-0716","article-title":"Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling","volume":"7","author":"Chaudhuri","year":"2017","journal-title":"Cancer Discov"},{"key":"key20240125114948_b19-ol-27-2-14185","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41571-018-0058-3","article-title":"Early stage NSCLC-challenges to implementing ctDNA-based screening and MRD detection","volume":"15","author":"Abbosh","year":"2018","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T09:51:28Z","timestamp":1706176288000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2023.14185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,12,12]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2023.14185","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,12]]},"article-number":"51"}}